PSR SUPPLIER REPORT
Independent review of supplier documentation, analytical testing evidence, lot traceability, pricing visibility, and company transparency.
REPORT STATUS
Initial Review
LAST REVIEWED
September 2026
SUPPLIER TYPE
Research-use supplier
LOCATION LISTED
USA
AFFILIATE DISCLOSURE
PSR may receive compensation when visitors access Evolve Peptides through certain referral links. Affiliate relationships do not determine PSR scores, methodology, findings, rankings, or editorial conclusions.
PRELIMINARY PSR ASSESSMENT
88 / 100 · STRONG TRANSPARENCY
WEIGHTED OVERALL PSR TRANSPARENCY SCORE
88 / 100
Preliminary assessment pending continued documentation review. Scores reflect transparency evidence and are not a certification, guarantee, safety determination, or human-use recommendation.
DOCUMENTATION QUALITY · 25%
90 / 100
TESTING EVIDENCE · 25%
88 / 100
LOT TRACEABILITY · 20%
91 / 100
PRICING TRANSPARENCY · 15%
95 / 100
SUPPLIER TRANSPARENCY · 15%
77 / 100
EXECUTIVE SUMMARY
A neutral reading of the public record.
Evolve Peptides maintains a public documentation system centered on batch-number COA lookup, public product pricing, research-use disclosures, and supplier claims of third-party analytical testing. Its COA lookup states that each batch is lab-tested before shipment and that researchers can enter the batch number from the product label to retrieve the corresponding Certificate of Analysis and endotoxin report.
For this initial review, PSR found strong transparency signals in Evolve’s batch-level lookup structure, public pricing, quantity discounts, product-level technical information, and disclosure of independent laboratory testing. The supplier publicly references Chromate, Janoshik, and MZ Biolabs as testing partners and states that testing includes purity, sterility, endotoxins, and heavy metals.
Areas requiring further review include direct PSR examination of a broader sample of batch reports, consistency between testing claims and individual certificates, and reconciliation of supplier address information across current policy pages.
PSR’s assessment reflects documentation transparency and evidence availability. It is not a certification or determination of product safety, efficacy, regulatory status, or suitability for human use.
01 / DOCUMENTATION REVIEW
Documentation Quality
POSITIVE EVIDENCE
• Public batch-number COA lookup
• COA and endotoxin report retrieval structure
• Batch number tied to product label
• Independent laboratory testing publicly stated
• Named third-party laboratories publicly stated
• Public product pricing
• Product strength displayed
• Stock status displayed
• Quantity-based pricing displayed
• Public shipping information
• Public research-use positioning
• Public contact email and mailing information
OPEN QUESTIONS
• Whether every active lot currently has a retrievable public report • Whether all listed testing endpoints appear on every corresponding batch certificate • Whether the same third-party laboratories are used consistently across the catalog • Whether PSR can independently verify a representative sample of current COA report IDs • How the supplier’s Wyoming and Florida address references relate to legal, mailing, or fulfillment operations • Whether historical batch documentation remains accessible after inventory turns over
PSR OBSERVATION
Evolve Peptides demonstrates a strong public documentation framework, particularly through batch-number lookup and public product-level information. PSR gives credit for that accessibility while distinguishing between supplier-stated testing practices and laboratory evidence that PSR has directly reviewed.
02 / TESTING EVIDENCE
Evolve Peptides maintains a public batch-number COA lookup and states that each batch is tested by independent third-party laboratories before shipment. The supplier publicly describes testing for purity, sterility, endotoxins, and heavy metals and identifies Chromate, Janoshik, and MZ Biolabs as third-party testing partners.
Public COA Lookup — Present · Batch Search — Present · HPLC Purity — Supplier-Stated · Mass Spectrometry Identity — Supplier-Stated · Sterility Testing — Supplier-Stated · Endotoxin Testing — Supplier-Stated · Heavy Metals Testing — Supplier-Stated · Named Third-Party Laboratories — Present
PSR NOTE
Evolve Peptides provides a relatively strong public testing framework, including batch-number lookup and named third-party laboratories. However, PSR distinguishes between supplier-wide testing claims and individual laboratory reports directly reviewed by PSR. Broader catalog-wide claims remain supplier-stated until a representative set of batch reports is independently examined.
SUPPLIER-STATED
Claims made by Evolve Peptides that PSR has not independently substantiated beyond supplier-provided information.
DOCUMENT OBSERVED
Information directly displayed in Evolve Peptides’ public COA lookup, product pages, policies, or other publicly accessible documentation.
PSR CONCLUSION
A preliminary interpretation limited to the evidence available at the time of review and subject to additional certificate verification.
03 / SAMPLE COA OBSERVATIONS
CERTIFICATE 01 / DOCUMENT OBSERVED
Semax 5 mg
Current Lot Number
7678381156
Supplier-Displayed Purity
99.292%
COA Availability
Latest COA shown in product gallery
Batch Verification
Available through Evolve’s lot-number lookup
Direct PSR Lab Report Review
Pending
CERTIFICATE 02 / DOCUMENT OBSERVED
Reta 10 mg
Current Lot Number
1924414129
Supplier-Displayed Purity
99.570%
COA Availability
Latest COA shown in product gallery
Batch Verification
Available through Evolve’s lot-number lookup
Direct PSR Lab Report Review
Pending
The lot numbers and purity values above were directly observed on current Evolve Peptides product pages. PSR has not yet independently validated the underlying laboratory reports for these specific lots. Accordingly, the purity values are reported as supplier-displayed data rather than independently verified PSR findings.
04 / LOT TRACEABILITY
Lot Traceability
Evolve Peptides’ public documentation links product labels to batch numbers and provides a batch-number lookup system for retrieving corresponding Certificates of Analysis. Current product pages display specific lot numbers, helping connect listed inventory to batch-level documentation.
Positive Indicators
• Batch number displayed on current product pages
• Public lot-number lookup available
• COA retrieval tied to batch number
• Product identity tied to listed lot
• Current lot data publicly displayed on at least some products
• Supplier states each batch is tested before shipment
Limitation
PSR has not independently verified the complete chain of custody from manufacturing through laboratory submission, warehousing, and final fulfillment. The batch-number system is a strong documentation signal, but it does not by itself establish end-to-end chain-of-custody verification.
05 / PRICING VISIBILITY
Pricing Visibility
Evolve Peptides publicly displays product prices, strengths, sale pricing, stock status, quantity-based discounts, and shipping information across its catalog. Pricing can be viewed without creating an account, which supports straightforward supplier-to-supplier comparison.
PSR Observation — Evolve Peptides provides strong pricing transparency. Researchers can review listed prices, strengths, sale pricing, quantity discounts, and stock status without registering for an account, which makes standardized comparison easier than with suppliers that restrict pricing visibility.
06 / COMPANY & SUPPLIER TRANSPARENCY
Supplier Name — Evolve Peptides · Country Positioning — USA · Public Contact Email — Available · Public Mailing Address — Available · Shipping Policy — Available · Refund Policy — Available · Research-Use Disclaimer — Available · Public Terms/Policy Pages — Available
PSR Observation — Evolve Peptides provides substantial public-facing business and policy information, including contact details, research-use language, shipping information, and customer policies. However, current supplier pages reference both Wyoming and Florida addresses. PSR treats this as a location-context issue requiring clarification rather than evidence of wrongdoing, because mailing, legal, fulfillment, and operating addresses can differ.
ITEMS REQUIRING CONTEXT
Wyoming vs. Florida address references · Public legal-entity identification · Fulfillment-location clarity · Long-term consistency of policy and testing disclosures
07 / EVIDENCE CLASSIFICATION
VERIFIED IN PUBLIC DOCUMENTATION — PSR directly observed Evolve Peptides’ public COA lookup, batch-number search structure, current lot numbers on product pages, supplier-displayed purity values, public pricing, stock status, quantity discounts, shipping information, contact information, and research-use policies. SUPPLIER-STATED — Evolve Peptides states that every batch is independently tested before shipment and that testing includes purity, sterility, endotoxins, heavy metals, and other analytical endpoints through third-party laboratories. NOT DETERMINED — PSR has not yet independently verified a broad sample of current laboratory reports, complete chain of custody, whether every active lot receives the same testing panel, or the exact relationship between the supplier’s Wyoming and Florida address references.
08 / BALANCED ASSESSMENT
DOCUMENTATION STRENGTHS
Public batch-number COA lookup · Current lot numbers displayed on product pages · Supplier-displayed purity values · Named third-party laboratories · Public pricing · Public stock status · Quantity-based discounts · Public shipping information · Public research-use policies · Public contact information
AREAS FOR FURTHER REVIEW
Direct review of a broader sample of laboratory reports · Complete chain-of-custody verification · Consistency of testing panels across all products · Whether every active lot has retrievable documentation · Wyoming vs. Florida address context · Public legal-entity identification · Long-term historical COA accessibility
PSR ASSESSMENT
Preliminary PSR Transparency Score: 88 / 100 — Strong Transparency
Evolve Peptides presents a strong public transparency framework, especially through its batch-number lookup system, visible lot information, public pricing, and supplier disclosure of third-party testing practices. These features support a strong preliminary PSR transparency assessment.
The main limitations are the amount of laboratory evidence PSR has directly reviewed, unresolved address-context questions, and the need to confirm whether all active products and lots receive the same testing panel. PSR does not treat supplier-stated purity figures, COA availability, or third-party testing claims as proof of product safety, efficacy, regulatory compliance, or complete chain of custody.
09 / SOURCES REVIEWED
Evolve Peptides official website - Evolve Peptides public COA lookup - Evolve Peptides product pages - Evolve Peptides shipping policy - Evolve Peptides refund / policy pages - Evolve Peptides affiliate program page - Public supplier contact information - Public statements identifying Chromate, Janoshik, and MZ Biolabs as third-party testing partners
DISCLAIMER
PSR evaluates supplier transparency and publicly available documentation for informational and research purposes. A PSR score is not a certification, laboratory guarantee, medical recommendation, safety determination, regulatory approval, or guarantee of product identity, purity, efficacy, legality, or suitability for human or animal use. Supplier-displayed purity values and supplier-stated testing claims remain classified as such unless directly substantiated by independently reviewed laboratory documentation.